SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-275161
Filing Date
2021-09-16
Accepted
2021-09-16 16:26:07
Documents
12
Period of Report
2021-09-15
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d226056d8k.htm   iXBRL 8-K 22415
  Complete submission text file 0001193125-21-275161.txt   144023

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA slrx-20210915.xsd EX-101.SCH 2916
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE slrx-20210915_lab.xml EX-101.LAB 18139
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE slrx-20210915_pre.xml EX-101.PRE 11424
5 EXTRACTED XBRL INSTANCE DOCUMENT d226056d8k_htm.xml XML 3402
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36812 | Film No.: 211258198
SIC: 2834 Pharmaceutical Preparations